Final analysis results from TITAN

Page 1

A phase 3 study of apalutamide vs placebo in patients with metastatic hormone-sensitive prostate cancer receiving androgen deprivation therapy

K. Chi et al. Poster presented at ASCO Genitourinary Cancers Symposium; February 11-13, 2021. San Francisco, CA

Janssen-Cilag NV - CP-211813 - 17-feb-2021 – vu/er Luc Van Oevelen, Antwerpseweg 15-17, 2340 Beerse

Final analysis results from TITAN:


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
Final analysis results from TITAN by Janssen - Issuu